Today, the cells used for ALECSAT therapy are dispatched with an expiry specification of 6 hours without loss of quality.

To further improve handling of cells new activities involving freezing of cells are ongoing.

Cytovac’s ALECSAT technology can easily be implemented at any immunotherapy center or cancer clinic globally where handling of human cells takes place.

Error, cant find that post.